Cibus, Inc. announced significant advancements in its gene editing technology, particularly the establishment of production standards for its proprietary RTDS gene editing system, which enables the ...

The EU has eased restrictions on crops developed using novel genetic techniques. While supporters say the technology could ...

Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...

Alternative splicing is a genetic process where different segments of genes are removed, and the remaining pieces are joined together during transcription to messenger RNA (mRNA). This mechanism ...

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to ...

Alternative splicing is a genetic process where different segments of genes are removed, and the remaining pieces are joined together during transcription to messenger RNA (mRNA). This mechanism ...

Dynamic gene expression changes often specify mechanisms through which cells determine state and function. Indeed, tightly regulated gene cascades underlie a myriad of fundamental processes, such as ...

Alternative splicing is a genetic process where different segments of genes are removed, and the remaining pieces are joined together during transcription to messenger RNA (mRNA). This mechanism ...

Blood stem cells with driver mutations may be more likely to survive during clonal expansion. Some of these driver mutations have been linked with cancer in other ...

CU Boulder researcher Jesse Kurland shows in new study that aging is a complex process affecting genetic networks, and altering one gene won’t stop it As anyone who’s ever said “oof” while sitting ...